Interview
Published in:
Volume 13 / Year 2024 / Issue 3
Volume 13 / Year 2024 / Issue 3
Transforming healthcare: CinnaGen’s leadership in follow-on biologicals/biosimilars development and market expansion
Author(s): GaBI Journal Editor
Page: 168-70
Page: 168-70
Abstract: CinnaGen, the largest biopharmaceutical company in the MENA region, is a leader in developing follow-on biologicals/biosimilars. Dr Haleh Hamedifar, Chairperson of CinnaGen, spoke to GaBI (Generics and Biosimilars Initiative)… Read More »